Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes
Teva Pharmaceutical Industries Ltd.’s credit rating was cut into junk territory by Moody’s Investors Service, adding to the company’s woes as revenue from its bestselling drug drops and it sells assets ...